Biochemical studies of vascular endothelial growth factor in patients with liver diseases / Heba Mohamed Mohamed Shehata ; Supervised Abdelgawad Ali Fahmi , Mohamed Ali Eldesouky , Amal Mohamed Ahmed
Material type:
- دراسات كيميائية حيوية لعامل النمو للخلايا المبطنة للأوعية الدموية فى مرضى الكبد [Added title page title]
- Issued also as CD
Item type | Current library | Home library | Call number | Copy number | Status | Barcode | |
---|---|---|---|---|---|---|---|
![]() |
قاعة الرسائل الجامعية - الدور الاول | المكتبة المركزبة الجديدة - جامعة القاهرة | Cai01.12.02.M.Sc.2012.He.B (Browse shelf(Opens below)) | Not for loan | 01010110059813000 | ||
![]() |
مخـــزن الرســائل الجـــامعية - البدروم | المكتبة المركزبة الجديدة - جامعة القاهرة | Cai01.12.02.M.Sc.2012.He.B (Browse shelf(Opens below)) | 59813.CD | Not for loan | 01020110059813000 |
Browsing المكتبة المركزبة الجديدة - جامعة القاهرة shelves Close shelf browser (Hides shelf browser)
No cover image available | No cover image available | No cover image available | No cover image available | No cover image available | No cover image available | No cover image available | ||
Cai01.12.02.M.Sc.2012.Fa.R The role of E-cadherin as tumour marker for breast cancer / | Cai01.12.02.M.Sc.2012.Fa.R The role of E-cadherin as tumour marker for breast cancer / | Cai01.12.02.M.Sc.2012.He.B Biochemical studies of vascular endothelial growth factor in patients with liver diseases / | Cai01.12.02.M.Sc.2012.He.B Biochemical studies of vascular endothelial growth factor in patients with liver diseases / | Cai01.12.02.M.Sc.2012.He.M Molecular markers predicting the efficacy of interferon - based therapies in patients with chronic hepatitis C / | Cai01.12.02.M.Sc.2012.He.M Molecular markers predicting the efficacy of interferon - based therapies in patients with chronic hepatitis C / | Cai01.12.02.M.Sc.2012.Kh.N Neurotoxic effect of some posticides on brain development and thyroid hormones / |
Thesis (M.Sc.) - Cairo University - Faculty of Science - Department of Biochemistry
Chronic infection with hepatitis C virus (HCV) is a well established risk factor for the development of hepatocellular carcinoma (HCC) and in many areas of the world is the predominant etiology for hepatocarcinogenesis . The prevalence of HCV infection varies throughout the world , the highest number of infections is reported in Egypt . HCV accounts for about 70% of cases with chronic hepatitis , 40% with cirrhosis , 60% with HCC and 15 - 30% of liver transplantation
Issued also as CD
There are no comments on this title.